Mirae Asset Global Investments Co. Ltd. Acquires 7,443 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Mirae Asset Global Investments Co. Ltd. increased its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 69.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 18,092 shares of the company’s stock after buying an additional 7,443 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Bath & Body Works were worth $586,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of BBWI. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in shares of Bath & Body Works by 28.1% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 258,617 shares of the company’s stock worth $12,936,000 after acquiring an additional 56,764 shares in the last quarter. Russell Investments Group Ltd. boosted its stake in Bath & Body Works by 46.9% in the 1st quarter. Russell Investments Group Ltd. now owns 131,605 shares of the company’s stock worth $6,572,000 after purchasing an additional 41,995 shares during the period. Vanguard Group Inc. grew its holdings in Bath & Body Works by 4.2% during the 1st quarter. Vanguard Group Inc. now owns 27,398,192 shares of the company’s stock valued at $1,370,458,000 after buying an additional 1,102,124 shares in the last quarter. SG Americas Securities LLC increased its position in shares of Bath & Body Works by 968.1% during the first quarter. SG Americas Securities LLC now owns 190,758 shares of the company’s stock valued at $9,542,000 after buying an additional 172,898 shares during the period. Finally, UniSuper Management Pty Ltd lifted its holdings in shares of Bath & Body Works by 576.9% in the first quarter. UniSuper Management Pty Ltd now owns 22,799 shares of the company’s stock worth $1,140,000 after buying an additional 19,431 shares in the last quarter. 95.14% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, CEO Gina Boswell purchased 6,000 shares of the company’s stock in a transaction on Wednesday, October 9th. The stock was acquired at an average price of $29.64 per share, with a total value of $177,840.00. Following the transaction, the chief executive officer now directly owns 242,987 shares of the company’s stock, valued at approximately $7,202,134.68. This represents a 0.00 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.27% of the stock is owned by insiders.

Bath & Body Works Stock Performance

Shares of Bath & Body Works stock opened at $28.92 on Friday. The stock has a market capitalization of $6.34 billion, a price-to-earnings ratio of 7.00, a price-to-earnings-growth ratio of 0.90 and a beta of 1.79. The company has a fifty day moving average of $30.16 and a 200-day moving average of $37.38. Bath & Body Works, Inc. has a 52-week low of $26.20 and a 52-week high of $52.99.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. The firm had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.54 billion. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. On average, equities research analysts forecast that Bath & Body Works, Inc. will post 3.18 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 6th. Stockholders of record on Friday, August 23rd were paid a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.77%. The ex-dividend date was Friday, August 23rd. Bath & Body Works’s dividend payout ratio (DPR) is presently 19.37%.

Analyst Ratings Changes

Several equities analysts recently commented on the stock. Raymond James reduced their price objective on shares of Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating for the company in a research note on Thursday, August 29th. Bank of America reduced their price target on shares of Bath & Body Works from $54.00 to $45.00 and set a “buy” rating for the company in a research report on Thursday, August 29th. Deutsche Bank Aktiengesellschaft lowered their price objective on Bath & Body Works from $57.00 to $54.00 and set a “buy” rating on the stock in a research report on Monday, August 26th. Telsey Advisory Group restated an “outperform” rating and set a $42.00 target price on shares of Bath & Body Works in a research report on Thursday, September 26th. Finally, Morgan Stanley lowered their price target on Bath & Body Works from $56.00 to $51.00 and set an “overweight” rating on the stock in a report on Thursday, September 5th. Seven investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat.com, Bath & Body Works currently has an average rating of “Moderate Buy” and a consensus price target of $43.13.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.